Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for Smoking Cessation
NCT01642433Phase 2Terminated
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jul 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prazosin in nicotine dependence, sponsored by Center for Addiction and Mental Health. Started Jul 2012; status: terminated.
02
Drugs
prazosin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01642433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642433.